DeciBio
Jessica Lee is a Product Manager at DeciBio since August 2015, where Jessica spearheaded the design and development of an expert insights platform called Dexter. Jessica has experience as a Co-Founder and Software Engineer at Armada, where Jessica architected a React application and deployed and managed Kubernetes clusters. Jessica also worked on Open Source Projects including 1PhotoADay and Wonderful Wunderpus, showcasing their skills in system construction and UI design. Jessica's educational background includes a BA in Biological Sciences from Cornell University and a Master's of Bioscience in Clinical & Regulatory Affairs from Keck Graduate Institute.
This person is not in the org chart
DeciBio
1 followers
DeciBio Consulting is a boutique strategy consulting firm focusing on the life science industry. DeciBio's mission is to provide the strategic insights that accelerate the development, adoption, and accessibility of personalized medicine. Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 life science corporations. DeciBio addresses business solutions that range from market landscape analyses to full commercial strategies, including organic and inorganic growth opportunities (commercial due diligences). DeciBio’s work is typically supported by a mix of primary and secondary research leveraging Dexter, its in-house expert network, and DeciBio Analytics’ proprietary data intelligence products. DeciBio’s Analytics division offers numerous data products to support strategic insights, including in clinical diagnostics (the DxBooks), immuno-oncology (the I/O BioMAP), omics market segmentation (the MarketBooks), and the entire life sciences industry (BioTrack). Internal teams such as the Culture Committee, Women* in Consulting, and Gays in Consulting enrich the employee experience. DeciBio’s Social Impact board and the DeciBio Impact Lab work collaboratively across divisions and externally to uproot discrimination and increase access to precision medicine.